European Journal of Pediatrics

, Volume 151, Issue 1, pp 15–18 | Cite as

Is testosterone therapy for boys with constitutional delay of growth and puberty associated with impaired final height and suppression of the hypothalamo-pituitary-gonadal axis?

  • M. Uruena
  • S. Pantsiotou
  • M. A. Preece
  • R. Stanhope


We report the treatment of 44 boys with constitutional delay of growth and puberty (CDGP) at a mean chronological age of 14.3 years (range, 12.4–17.1) and bone age of 12.1 years (range, 9.1–15.0). All were below the 3rd height percentile for chronological age. They reccived monthly intramuscular injections of depot testosterone esters (50 mg) for a mean period of 0.35 years (range, 0.25–0.5). Means (SD) height velocity was 4.5 (1.5) cm/year during a pretreatment period of 0.5 years. During a period of 0.9 years which included the period of treatment with depot testosterone, mean growth velocity increased to 8.8 (1.9) cm/year (P<0.001). In the initial 1.8 years following the cessation of treatment growth velocity was sustained at 7.0 (1.7) cm/year. Pretreatment height standard deviation score (SDS) for bone age was −0.89 and this gradually reduced over the next 1.5 years to a minimum of −1.48. Thereafter, height SDS for bone age gradually increased to attain a value of −1.2, 3 years after the commencement of therapy (P<0.02). The same pattern of an initial decrease, followed by an increase, in height prediction was also observed when TW2 height prediction was analysed. Sexual maturation progressed during treatment, with mean testicular volume increasing both during and after treatment, confirming the diagnosis of CDGP. The time interval for progress through puberty was shorter in boys with testosterone therapy than in the normal population. The mean duration of puberty was 2.2 years compared to 3.3 years in normal boys. We conclude that low-dose depot testosterone treatment is safe and effective for boys with CDGP. At the dose regimen used there was no suppression of testicular enlargement. Initial decrease in height prediction concomitant with depot testosterone therapy may be misleading.

Key words

Constitutional delay Testosterone Sexual maturation Height prognosis 



constitutional delay of growth and puberty


standard deviation score


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bierich JR (1986) Treatment by hGH of constitutional delay of growth and adolescence. Acta Paediatr Scand [Suppl] 325:71–75Google Scholar
  2. 2.
    Blethen SL, Gaines S, Weldon V (1984) Comparison of predicted and adult heights in short boys: effect on androgen therapy. Pediatr Res 18:467–469Google Scholar
  3. 3.
    Bramswig JH, Fasse M, Holthoff ML, Lengerke HJ von, Petrykowski W von, Schellong G (1990) Adult height in boys and girls with untreated short stature and constitutional delay of growth and puberty: accuracy of five different methods of height prediction. J Pediatr 117:886–891Google Scholar
  4. 4.
    Brook CGD (1982) Growth assessment in childhood and adolescence. Blackwell Scientific Publication, OxfordGoogle Scholar
  5. 5.
    Buyukgebiz A, Hindmarsh PC, Brook CGD (1990) Treatment of constitutional delay of growth and puberty with oxandrolone compared with growth hormone. Arch Dis Child 65:448–452Google Scholar
  6. 6.
    Crowne EC, Shalet SM, Wallace WHB, Eminson DM, Price DA (1990) Final height in boys with untreated constitutional delay in growth and puberty. Arch Dis Child 65:1109–1112Google Scholar
  7. 7.
    Dannerhoffer R, Crawford JD (1983) Testosterone need questioned. Pediatrics 71:666–667Google Scholar
  8. 8.
    Eastman JM, Lasarus L, Stuart MC, Casey JH (1971) The effect of puberty on growth hormone secretion in boys with short stature and delayed adolescence. Aust NZ J Med 1:154–159Google Scholar
  9. 9.
    Geller J (1968) Oxandrolone effect on growth and bone age in idiopathic growth failure. Acta Endocrinol (Copenh) 59:307–316Google Scholar
  10. 10.
    Gordon M, Crouthamel C, Post EM, Richman RA (1982) Psychological aspects of constitutional short stature: social competence. behaviour problems, self-esteem and family functioning. J Pediatr 101:477–480Google Scholar
  11. 11.
    Hopwood NJ, Kelch RP, Zipf WB, Hernandez RJ (1979) The effect of synthetic androgens on the hypothalamo-pituitary gonadal axis in boys with constitutionally delayed growth. J Pediatr 94:657–662Google Scholar
  12. 12.
    Jackson ST, Rallison ML, Buntin WH, Johnson SB, Flynn RR (1973) Use of oxandrolone for growth stimulation in children. Am J Dis Child 126:481–484Google Scholar
  13. 13.
    Kaplan JG, Moshang T, Bernstein R, Parks JS, Bongiovanni AM (1973) Constitutional delay of growth and development: effects of treatment with androgens. J Pediatr 82:38–44Google Scholar
  14. 14.
    Lange WE de, Snoep MC, Doovenbos H (1979) The effect of short-term testosterone treatment in boys with delayed puberty. Acta Endocrinol 91:177–183Google Scholar
  15. 15.
    Marshall WA, Tanner JM (1970) Variations in pattern of pubertal changes in boys. Arch Dis Child 45:13–23Google Scholar
  16. 16.
    Marti-Henneberg C, Niirianen AK, Rappaport R (1975) Oxandrolone treatment of constitutional short stature in boys during adolescence: effect on linear growth, bone age, pubic hair, and testicular development. J Pediatr 86:783–788Google Scholar
  17. 17.
    Martin MM, Martin ALA, Mossman KL (1986) Testosterone treatment of constitutional delay in growth and development: effect of dose on predicted versus definitive height. Acta Endocrinol 279 [Suppl]:147–152Google Scholar
  18. 18.
    Prader A (1975) Delayed adolescence. Clin Endocrinol Metab 4:143–155Google Scholar
  19. 19.
    Prader A (1986) Paediatric endocrinology: past and future. In: Ranke MB, Bierich JB (eds) Paediatric endocrinology. MD-Verlag, Munich, pp 13–21Google Scholar
  20. 20.
    Richman RA, Kirsch LR (1988) Testosterone treatment in adolescent boys with constitutional delay in growth and development. N Engl J Med 319:1563–1567Google Scholar
  21. 21.
    Rosenfeld RG, Northcroft GB, Hintz RL (1982) A prospective, randomised study of testosterone treatment of constitutional delay of growth and development in male adolescents. Pediatrics 69:681–687Google Scholar
  22. 22.
    Stanhope R, Brook CGD (1985) Oxandrolone in low dose for constitutional delay of growth and puberty in boys. Arch Dis Child 60:379–381Google Scholar
  23. 23.
    Stanhope R, Bommen M, Brook CGD (1985) Constitutional delay of growth and puberty: the effect of short course of treatment with Fluoxymesterone. Acta Paediatr Scand 74:390–393Google Scholar
  24. 24.
    Styne DM (1987) Delayed puberty. In: Hintz RL, Rosenfeld RG (eds) Growth abnormalities. Churchill Livingstone Inc, New York, pp 141–165Google Scholar
  25. 25.
    Tanner JM (1968) Growth at adolescence, 2nd edn. Blackwell Scientific Publications, OxfordGoogle Scholar
  26. 26.
    Tanner JM, Whitehouse RH, Takaishi M (1965) Standards from birth to maturity of height, weight, height velocity and weight velocity: British children, 1965 Part I. Arch Dis Child 41:454–471Google Scholar
  27. 27.
    Tanner JM, Whitehouse RH, Takaishi M (1965) Standards from birth to maturity for height, weight height velocity and weight velocity: British Children, 1965 Part II. Arch Dis Child 41:613–635Google Scholar
  28. 28.
    Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H (1983) Assessment of skeletal maturity and prediction of adult height, 2nd edn. Academic Press, LondonGoogle Scholar
  29. 29.
    Wilson DM, Kei J, Mintz RL, Rosenfeld RG (1988) Effects of testosterone therapy for pubertal delay. Am J Dis Child 142:96–99Google Scholar
  30. 30.
    Zachmann M, Prader A, Kind HP, Hafliger H, Budliger H (1974) Testicular volume during adolescence. Helv Paediatr Acta 29:61–72Google Scholar
  31. 31.
    Zachmann M, Studer S, Prader A (1987) Short-term testosterone treatment at bone age of 12 to 13 years does not reduce adult height in boys with constitutional delay of growth and adolescence. Helv Paediatr Acta 42:21–28Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • M. Uruena
    • 1
  • S. Pantsiotou
    • 1
  • M. A. Preece
    • 1
  • R. Stanhope
    • 1
  1. 1.Medical UnitInstitute of Child HealthLondonUK

Personalised recommendations